ArcTern Ventures invests in Kebotix’s Series A financing

Kebotix, a Cambridge, Massachusetts-based technology platform for new chemicals and materials, announced ArcTern Ventures was a major investor in its previously disclosed US$11.4 million Series A financing.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this